Small-molecule SMAC mimetics as new cancer therapeutics-Reference-Cited by-同舟云学术

Small-molecule SMAC mimetics as new cancer therapeutics

Published:2014-10 Issue:1 Volume:144 Page:82-95
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Bai Longchuan,Smith David C.,Wang Shaomeng

Funder

Breast Cancer Research Foundation

Prostate Cancer Foundation

Department of Defense Prostate Cancer Program

Ascenta Therapeutics

Debiopharm

National Cancer Institute

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference150 articles.

1. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex;Abhari;Oncogene,2013

2. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-alpha-independent mechanism;Allensworth;Breast Cancer Res Treat,2013

3. Phase 1 study of the Smac mimetic TL32711 in adult subjects with advanced solid tumors and lymphoma to evaluate safety, pharmacokinetics, pharmacodynamics, and antitumor activity;Amaravadi,2011

4. A phase I study of birinapant (TL32711) combined with multiple chemotherapies evaluating tolerability and clinical activity for solid tumor patients;Amaravadi;J Clin Oncol,2013

5. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma;Annunziata;Cancer Cell,2007

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E3 ubiquitin ligase gene BIRC3 modulates TNF-induced cell death pathways and promotes aberrant proliferation in rheumatoid arthritis fibroblast-like synoviocytes;Frontiers in Immunology;2024-09-05

2. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-30

3. Inhibition of IAPs induces programmed cell death and inflammatory signaling in patient-derived metastatic breast cancer organoids;2024-08-28

4. Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition;Molecules;2024-08-23

5. SMAC Mimetics for the Treatment of Lung Carcinoma: Present Development and Future Prospects;Mini-Reviews in Medicinal Chemistry;2024-08